{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:33:11Z","timestamp":1791923591395,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jad.2017.03.054","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T16:33:33Z","timestamp":1490632413000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations"],"prefix":"10.1016","volume":"217","author":[{"given":"Louise","family":"Wing\u00e5rd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bod\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Kieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Reutfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.03.054_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.01.017","article-title":"Quetiapine and classical mood stabilizers in the long-term treatment of bipolar disorder: a 4-year follow-up naturalistic study","volume":"110","author":"Altamura","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.03.054_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2008.59.10.1175","article-title":"Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence","volume":"59","author":"Baldessarini","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2017.03.054_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/neu.2015.52","article-title":"Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study","volume":"28","author":"Bjorklund","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jad.2017.03.054_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/appi.ajp.2008.08060967","article-title":"Bipolar drug development: are we getting closer to the real world?","volume":"165","author":"Calabrese","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/JCP.0000000000000440","article-title":"Utilization of psychopharmacological treatment among patients with newly diagnosed bipolar disorder from 2001 to 2010","volume":"36","author":"Chang","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.03.054_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2007.03.003","article-title":"Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study","volume":"104","author":"Garnham","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.03.054_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jad.2010.11.037","article-title":"Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--Results of a two year observational study in bipolar disorder (EMBLEM)","volume":"131","author":"Gonzalez-Pinto","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.03.054_bib8","first-page":"819","article-title":"Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?","volume":"25","author":"Goodwin","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2017.03.054_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.03.054_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The world Federation of societies of biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20298","article-title":"Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records","volume":"15","author":"Hayes","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/11535200-000000000-00000","article-title":"The cost of relapse for patients with a manic\/mixed episode of bipolar disorder in the EMBLEM study","volume":"28","author":"Hong","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jad.2017.03.054_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1192\/bjp.bp.110.084822","article-title":"Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study","volume":"199","author":"Kessing","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/0269881111414091","article-title":"An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder","volume":"26","author":"Kessing","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.03.054_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-244X-12-228","article-title":"Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice","volume":"12","author":"Kulkarni","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib16","series-title":"Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations","first-page":"237","author":"Lee","year":"1992"},{"key":"10.1016\/j.jad.2017.03.054_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jad.2017.03.054_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hup.2445","article-title":"Pharmacotherapy in bipolar disorders during hospitalization and at discharge predicts clinical and psychosocial functioning at follow-up","volume":"29","author":"Pompili","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.03.054_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.pnpbp.2009.03.024","article-title":"Observational study designs for bipolar disorder - What can they tell us about treatment in acute mania?","volume":"33","author":"Reed","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ps.2007.58.6.855","article-title":"Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder","volume":"58","author":"Sajatovic","year":"2007","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2017.03.054_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4088\/JCP.13m08601","article-title":"A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients","volume":"75","author":"Simhandl","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib23","article-title":"National guidelines for care in cases of depression and anxiety disorders","author":"The Swedish National Board of Health and Welfare","year":"2010","journal-title":"V\u00e4ster\u00e5s"},{"key":"10.1016\/j.jad.2017.03.054_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.03.054_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish prescribed drug register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2017.03.054_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.03.054_bib27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Mol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716323540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716323540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T05:58:04Z","timestamp":1535954284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032716323540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":27,"alternative-id":["S0165032716323540"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.03.054","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}